Ann: SNT to present in MST Access Hidden Gems Webinar, page-29

Investors may find this useful:-

Source: The Motley Fool Australia Warning: Every investor should read this before buying speculative biotech companies

https://search.app/KrD51ZJ6TjZSaafV8

My investment is pure speculation and not a king’s ransom. I’d be happier if SNT starts to think strategic eg future finance looking, like merging to protect its IP. As it looks ATM the company isn’t generating sufficient revenue to sustain its R&D program. It will need to re-finance at some stage in 2024/25. My opinion only.